Set-Valued Control of Cancer by Combination Chemotherapy
Abstract
Keywords
References
- [1] Y. Batmani, H. Khaloozadeh, Multi objective optimization of drug regimens in cancer chemotherapy using a PK-PD model, 19th Iranian Conference on Electrical Engineering, (2011), 1-1.
- [2] A. Floares, C. Floares, M. Cucu, L. Lazar, Adaptive neural networks control of drug dosage regimens in cancer chemotherapy, Proceedings of the International Joint Conference on Neural Networks, 1 (2003), 154-159.
- [3] M. M. Hadjiandreou, G. D. Mitsis, Mathematical modeling of tumor growth, drug-resistance, toxicity, and optimal therapy design, IEEE Trans. Biomed. Eng., 61(2) (2014), 415-425.
- [4] A. Petrovski, J. McCall, B. Sudha, Multi-objective optimization of cancer chemotherapy using swarm intelligence, AISB Symposium on Adaptive and Emergent Behaviour and Complex Systems, UK Society for AI, (2009).
- [5] A. Petrovski, J. McCall, Multi-objective optimisation of cancer chemotherapy using evolutionary algorithms, International Conference on Evolutionary Multi-Criterion Optimization, Springer, Berlin, Heidelberg, (2001).
- [6] J. McCall, Genetic algorithms for modelling and optimisation, J. Comput. Appl., 184(1) (2005), 205-222.
- [7] H. Khaloozadeh, Y. Pedram, H. S. Fatemeh, The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB, Math. Biosci., 213(2) (2008), 151-158.
- [8] T. Ajayi, S. Hosseinian, A. J. Schaefer, C. D. Fuller, Combination Chemotherapy Optimization with Discrete Dosing, arXiv preprint, (2021).
- [9] A. Petrovski, An application of genetic algorithms to chemotherapy treatment, Ph.D. Thesis, Robert Gordon University, 1998.
- [10] S. L. Thomson, G. Ochoa, The Local Optima Level in Chemotherapy Schedule Optimisation, European Conference on Evolutionary Computation in Combinatorial Optimization (Part of EvoStar), Springer, Cham, (2020).
